Skip to main content

Home/ MaRS/ Group items tagged Tom Hudson

Rss Feed Group items tagged

Assunta Krehl

From `Eureka!' to real help for cancer patients - The Star - 0 views

  •  
    Tom Hudson is announced as the President and Scientific Director of the Ontario Institute for Cancer Research (OICR).
  •  
    Tom Hudson is announced as the President and Scientific Director of the Ontario Institute for Cancer Research (OICR). Nov 13, 2006
Assunta Krehl

Ontario Institute for Cancer Research Plans Hires, Increased Commercial Activities - Ge... - 0 views

  •  
    The Ontario Institute for Cancer Research in 2010 will grow its workforce, step up efforts to commercialize discoveries, and aim to fulfill research goals to be detailed in a second strategic plan set to be submitted next month to provincial officials, according to the institute's president and scientific director, Tom Hudson.
Assunta Krehl

OICR invests $1 million in the further development of two new cancer treatments - Canad... - 0 views

  •  
    Dr. Tom Hudson, President and Scientific Director of the Ontario Institute for Cancer Research (OICR) announced an investment of $1 million towards the development of two new promising cancer therapies. OncoTek Drug Delivery Inc (a subsidiary of Receptor Therapeutics) is one of the recipients.
Assunta Krehl

Science City - The Globe and Mail - 0 views

  • This is Toronto's research district, a maze of concrete and glass where the finest minds collaborate, turning the city into a global centre of biomedical discovery.
  • Nine research institutes employing 5,000 university faculty members, 2,000 graduate students and 1,100 postdoctoral and clinical fellows lie within a 20-minute walk of each other. This biomedical cluster at the heart of Toronto is one of the largest on the continent, and is one of the 10 largest in the world.
  • Tom Hudson from Montreal; cell biologist Ben Neel from Boston; and stem-cell biologist Gordon Keller, who came to Toronto in 2006, just months after New York magazine named him one of the scientists that city could not afford to lose. Toronto is also home to Tak Mak, who discovered the "key to the immune system" T-cell receptor, and John Dick, who discovered the first cancer stem cell in 1994 and last year grew a human cancer in a lab mouse for the first time.
  • ...3 more annotations...
  • "There's an enthusiasm in the research community that's very exciting to be part of," says Dr. Keller, who now heads the McEwan Centre for Regenerative Medicine.
  • Dr. Hudson, who left Quebec to head the Ontario Institute for Cancer Research, says the city's "tremendous power" is built on a strong history: Stem-cell research began here. "It's innovative," he says of Toronto. "I've never felt closer in my research career to thinking we will have an impact. I feel my goals are going to happen here."
  • Still, John Evans, board chairman of the non-profit MaRS Centre, which helps to turn research into viable businesses, envisages a day when research is seen as a social and economic driver, and the city shines as brightly as better-known centres such as Boston and Palo Alto.
  •  
    Tenille Bonoguore, Globe and Mail features the MaRS Centre and meets 12 of its' "best specimens." MaRS is one of the 10 largest biomedical clusters in the continent.
  •  
    Tenille Bonoguore, Globe and Mail features the MaRS Centre and meets 12 of its' "best specimens." Bonoguore states "MaRS Centre is one of the 10 largest biomedical clusters in the continent." Jan 5, 2008
Assunta Krehl

Diamond Schmitt Architects to design cancer research lab space at MaRS in Toronto - Dai... - 0 views

  •  
    "Diamond Schmitt Architects will design research laboratory space for the Ontario Institute for Cancer Research (OICR) at the MaRS Phase II west tower currently under construction in downtown Toronto." MaRS Phase II occupancy is slatted for 2013.
1 - 5 of 5
Showing 20 items per page